Brain NeoplasmsColorectal NeoplasmsDNA-Binding Proteins
Dr. Stuart Louis Cramer, MD
NPI1831216472PAC ID0941485072
- Part D claims, 2022
- 13
- Publications
- 12
- Clinical trials
- 10
- Industry payments
- $1,664
- Affiliated sites
- 2
- Practice address
- 7 Richland Medical Park Dr, Columbia, SC 29203
- Practice phone
- Call (803) 545-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Prisma Health Medical Group-Midlands
Columbia, South Carolina
Find Dr. Cramer's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Stuart Louis Cramer is a pediatric hematology and oncology physician in Columbia, South Carolina
Dr. Cramer practices at Prisma Health Medical Group-Midlands in Columbia, South Carolina.
Dr. Cramer's NPI, 1831216472, was assigned on March 26, 2007. Dr. Cramer holds South Carolina license 925.
NPI and contact details
- NPI
- 1831216472NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0941485072
- NPI enumeration date
- March 26, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (803) 545-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Stuart Louis Cramer practices at Prisma Health Medical Group-Midlands in Columbia, South Carolina
Dr. Cramer's primary practice is Prisma Health Medical Group-Midlands, at 7 Richland Medical Park Dr, Columbia, SC 29203 in Richland County. The practice phone is (803) 545-5000.
- Prisma Health Medical Group-Midlands7 Richland Medical Park Dr, Columbia, SC 29203 · Richland CountyPhone(803) 545-5000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Stuart Louis Cramer is affiliated with 3 sites of care and 3 medical groups
Dr. Cramer's primary practice is Prisma Health Medical Group-Midlands in Columbia, South Carolina. The medical group on file is Prisma Health Medical Group-Midlands. Dmand AI also links Dr. Cramer to 2 more group practices and clinics and 2 medical groups, each named with a free account.
Prisma Health Medical Group-MidlandsPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Stuart Louis Cramer's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cramer practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Prisma Health Medical Group-Midlands | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Cramer practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Stuart Louis Cramer is one of 33 pediatric hematologys and oncology physicians in South Carolina
Pediatric hematology-oncology is Dr. Cramer's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Cramer's licenses on file in 2 states: South Carolina and Alabama.
Specialties and state licenses
- Pediatric hematology and oncology, South CarolinaPrimary
- Pediatrics, Alabama
Pediatric hematologys and oncology physicians near Dr. Cramer
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
33pediatric hematologys and oncology physicians in South Carolina
7pediatric hematologys and oncology physicians in Columbia
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Stuart Louis Cramer's patients have a median age of 13
Across all payers, Dmand AI patient panel data puts Dr. Cramer's median patient age at 13, with 44% women.
Dr. Cramer's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 13
Patient panel by sex, all payers
- Women44%
- Men56%
Source: Dmand AI Patient Panel Data
Dr. Stuart Louis Cramer wrote 13 Medicare Part D claims in 2022
In 2022, Dr. Cramer wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $2,892 in total drug cost. In 2016, CMS named 15 claims across 1 drug.
Part D claims, 202213
Drugs named by CMS1
Total drug cost$2,892
Dr. Cramer's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2016 to 2022
- 2016
- 2022
- Claims for drugs CMS names
- 2016: 152022: 1313%
Drugs named by CMS: 1 in 2022, 1 in 2016.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
How Dr. Stuart Louis Cramer takes part in Medicare
Dr. Cramer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find pediatric hematologys and oncology physicians like Dr. Cramer by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Stuart Louis Cramer has 12 publications on record
Dmand AI links 12 papers to Dr. Cramer, published from 2015 to 2024. The most frequent topics are Sarcoma, Repressor Proteins and Biomarkers, Tumor. Dr. Cramer's most frequent co-authors are Joseph G. Pressey, MD, David R. Kelly, MD and Jeffrey A. Knipstein, MD.
Papers12
Years published2015 to 2024
Dr. Cramer's papers by year, 2015 to 2024
Topics Dr. Cramer writes about most
- Sarcoma
- Repressor Proteins
- Biomarkers, Tumor
- Brain Neoplasms
- Genetic Predisposition to Disease
- Proto-Oncogene Proteins
- Soft Tissue Neoplasms
Dr. Cramer's most frequent co-authors
- Joseph G. Pressey, MD7 shared papers
- David R. Kelly, MD2 shared papers
- Jeffrey A. Knipstein, MD2 shared papers
Recent publications by Dr. Cramer
J Pediatr Hematol Oncol
Biomarkers, TumorCarboplatinCyclophosphamide
Brain NeoplasmsMelanomaProto-Oncogene Mas
Pediatr Blood Cancer
Attitude to HealthGenetic CounselingGenetic Predisposition to Disease
See who Dr. Cramer researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cramer works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Stuart Louis Cramer has worked on 10 clinical trials
Dmand AI links Dr. Cramer to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Fibrolamellar hepatocellular carcinoma, Glioblastoma and Hodgkin Disease. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Cramer by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Cramer's trials
- Fibrolamellar hepatocellular carcinoma
- Glioblastoma
- Hodgkin Disease
- Leukemia, Biphenotypic, Acute
- Medulloblastoma
Investigators on the most trials with Dr. Cramer
- Iftikhar Hanif, MD9 shared trials
- David L. Becton, MD8 shared trials
- Jamie L. Dargart, MD8 shared trials
Recent clinical trials with Dr. Cramer
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma (opens in a new tab)
Active, not recruitingPhase 3
Rhabdomyosarcoma, EmbryonalRhabdomyosarcoma, AlveolarCyclophosphamideDactinomycinVincristine Sulfate
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (opens in a new tab)
Active, not recruitingPhase 2
PheochromocytomaHistiocytosis, Langerhans-CellTipifarnib
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (opens in a new tab)
RecruitingPhase 3
CarboplatinSelumetinib SulfateVincristine Sulfate
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabDacarbazine
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations (opens in a new tab)
Active, not recruitingPhase 2
GlioblastomaAstrocytomaTemozolomideVeliparibRadiation Therapy
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Stuart Louis Cramer received $1,664 in industry payments from 2016 to 2025
CMS Open Payments shows 7 general payments to Dr. Cramer from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 94% of the total. Alexion Pharmaceuticals, Inc. paid the most, $1,608.
General payments to Dr. Cramer by program year, 2016 to 2025
General payments to Dr. Cramer by kind, 2016 to 2025
$1.7Kin total
- Consulting fees$1,56094%
- Food and beverage$1046%
Companies that paid Dr. Cramer the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Stuart Louis Cramer's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Stuart Louis Cramer
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Stuart Louis Cramer's NPI number?
Dr. Stuart Louis Cramer's NPI number is 1831216472. It was assigned on March 26, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Stuart Louis Cramer?
Dr. Stuart Louis Cramer is a pediatric hematology and oncology physician in Columbia, South Carolina. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Stuart Louis Cramer practice?
Dr. Cramer practices at 7 Richland Medical Park Dr, Columbia, SC 29203. Dr. Cramer's primary practice is Prisma Health Medical Group-Midlands in Columbia, South Carolina. Dmand AI also links Dr. Cramer to 2 group practices and clinics and 2 medical groups.
What is Dr. Stuart Louis Cramer's office phone number?
The practice phone on file for Dr. Cramer is (803) 545-5000.
What is Dr. Stuart Louis Cramer's medical license number?
Dr. Cramer holds South Carolina license 925, one of the licenses on file in 2 states.
Which states has Dr. Stuart Louis Cramer been licensed in?
Dmand AI has state licenses on file for Dr. Cramer in South Carolina and Alabama.
What medical group is Dr. Stuart Louis Cramer part of?
Dr. Cramer is linked to Prisma Health Medical Group-Midlands. Dmand AI links Dr. Cramer to 2 more medical groups.
Does Dr. Stuart Louis Cramer accept Medicare?
Yes. CMS lists Dr. Cramer as accepting Medicare assignment.
What drugs does Dr. Stuart Louis Cramer prescribe most?
In 2022 Medicare Part D data, Dr. Cramer's most prescribed drugs by claims were Deferasirox.
Has Dr. Stuart Louis Cramer received payments from drug or device companies?
CMS Open Payments shows $1,664 in general payments to Dr. Cramer from 4 companies from 2016 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. Stuart Louis Cramer been practicing?
Dr. Cramer graduated from medical school in 2005, 21 years ago.
Does Dr. Stuart Louis Cramer do research?
Dmand AI links 12 publications to Dr. Cramer, published from 2015 to 2024. Dr. Cramer has worked on 10 clinical trials.
Who does Dr. Stuart Louis Cramer publish with?
Dr. Cramer's most frequent co-authors are Joseph G. Pressey, MD (7 shared papers), David R. Kelly, MD (2 shared papers) and Jeffrey A. Knipstein, MD (2 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in South Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card